Nylander, L, Lugnegard, T, Hallerback, MU.
Autism spectrum disorders and schizophrenia spectrum disorders in adults: is there a connection? A literature review and some suggestions for future clinical research. Clin Neuropsychiatry J Treat Eval
2008; 5: 43–54.
Owen, MJ, O'Donovan, MC, Thapar, A, Craddock, N.
Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry
2011; 198: 173–5.
Chisholm, K, Lin, A, Abu-Akel, A, Wood, SJ.
The association between autism and schizophrenia spectrum disorders: a review of eight alternate models of co-occurrence. Neurosci Biobehav Rev
2015; 55: 173–83.
van Dooren, K, McPherson, L, Lennox, N.
Mapping the needs of adults with autism and co-morbid intellectual disability. Curr Dev Disord Rep
2016; 3: 82–9.
Raja, M, Azzoni, A.
Autistic spectrum disorders and schizophrenia in the adult psychiatric setting: diagnosis and comorbidity. Psychiatr Danub
2010; 22: 514–21.
Barneveld, PS, Pieterse, J, de Sonneville, L, van Rijn, S, Lahuis, B, van Engeland, H, et al.
Overlap of autistic and schizotypal traits in adolescents with autism spectrum disorders. Schizophr Res
2011; 126: 231–6.
Bevan, JR, Thapar, A, Lewis, G, Zammit, S.
The association between early autistic traits and psychotic experiences in adolescence. Schizophr Res
2012; 135: 164–9.
North, AS, Russell, AJ, Gudjonsson, GH.
High functioning autism spectrum disorders: an investigation of psychological vulnerabilities during interrogative interview. J Forens Psychiatry Psychol
2008; 19: 323–34.
van Os, J, Hanssen, M, Bijl, RV, Ravelli, A.
Strauss (1969) revisited: a psychosis continuum in the general population?
2000; 45: 11–20.
Lord, C, Rutter, M, Le Couteur, A.
Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord
1994; 24: 659–85.
Fleischhacker, WW, McQuade, RD, Marcus, RN, Archibald, D, Swanink, R, Carson, WH.
A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia. Biol Psychiatry
2009; 65: 510–17.
Mauri, MC, Moliterno, D, Rossattini, M, Colasanti, A.
Depression in schizophrenia: comparison of first-and second-generation antipsychotic drugs. Schizophr Res
2008; 99: 7–12.
La Grenade, L, Graham, D, Trontell, A.
Myocarditis and cardiomyopathy associated with clozapine use in the United States. N Engl J Med
2001; 345: 224–5.
Taylor, D, Paton, C, Kapur, S.
Maudsley Prescribing Guidelines (11th edn). Informa Healthcare, 2012.
Goodman, WK, Price, LH, Rasmussen, SA, Mazure, C, Fleischmann, RL, Hill, CL, et al.
The Yale–Brown Obsessive–Compulsive Scale: development, use, and reliability. Arch Gen Psychiatry
1989; 46: 1006–11.
Schirmbeck, F, Zink, M.
Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol
2012; 10: 88–95.
Samalin, L, Garnier, M, Llorca, PM.
Clinical potential of lurasidone in the management of schizophrenia. Ther Clin Risk Manag
2011; 7: 239.